Skeletalis Bio
PrivateLast Round
Seed
Nov 17, 2025
Total Funding Raised
$8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Skeletalis Bio is a biotechnology company developing a platform of targeted small-molecule therapeutics for treating osteoporosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Skeletalis Bio Comparables
Compare Skeletalis Bio with similar companies based on industry and business-model similarity.
Skeletalis Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 17, 2025 |
Skeletalis Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| age1 | Seed |
| Pillar VC | Seed |
| KdT Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 17, 2025
Raised $8M in a Seed round.
Skeletalis Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Skeletalis Bio's valuation, stock price, and market status.